secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001493152-25-005666
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health President resigns; appoints new director Ellen Beausang
-----------------------------------------------------------------------------

- Dr. Sandra Milligan resigns as President effective Feb 21, 2025, for personal reasons.
- Duties assumed by Jamie Sullivan (Chief of Staff) and Todd Pappas (VP R&D and Lab Ops).
- Ellen Beausang appointed to board; she is President/Chief Commercial Officer of BioReference Health (since June 2022).
- Beausang brings 25+ years experience from Pfizer, Thermo Fisher, Quest Diagnostics; no arrangement or related-party transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/0001493152-25-005666-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315225005666/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005666

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer